Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group
N Engl J Med. 2008 359 (21): 2195-207

PMID: 18997196 · DOI:10.1056/NEJMoa0807646

MeSH Terms (23)

Aged Biomarkers C-Reactive Protein Cardiovascular Diseases Cholesterol, LDL Diabetes Mellitus Double-Blind Method Female Fluorobenzenes Follow-Up Studies Glycated Hemoglobin A Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Kaplan-Meier Estimate Male Middle Aged Muscular Diseases Myocardial Infarction Proportional Hazards Models Pyrimidines Rosuvastatin Calcium Stroke Sulfonamides

Connections (1)

This publication is referenced by other Labnodes entities: